Better health starts with prevention. Virotek delivers advanced molecular genetic testing for medical clinics, employers, and individuals. Our results provide clear, trusted insights that help guide early prevention, personalized treatment, and better care.
Patient information is handled in accordance with HIPAA and applicable state privacy laws.
Providing equitable, accessible, affordable, and actionable genomic care for all
We make high-quality genetic testing more accessible to everyone regardless of background, income, or where they live.
We remove the logistical and financial barriers between patients and genomic testing — no long referral chains, no prohibitive costs.
We deliver a full spectrum of genomic care — from proactive screening and diagnostics to treatment — in one integrated platform.
Our pipelines translate complex genomic data into clear, actionable reports delivered within weeks.
Advanced genetic testing designed to empower prevention, early risk awareness, and personalized care—from monogenic to polygenic conditions, and pharmacogenomic panels.
Whole exome or whole genome sequencing to support carrier screening and diagnosis of unexplained, complex, or suspected inherited conditions when targeted panels are not conclusive.
Germline and tumor-based assays that help assess inherited risk, match therapy to molecular findings, and support monitoring when clinically appropriate.
Designed for population genetic testing
Screenome™ is Virotek’s most comprehensive genomic screening platform that integrates a full suite of clinically actionable reports into a single test, enabling personalized prevention, early risk detection, and proactive health management.
The result is four comprehensive reports, each addressing a critical aspect of your long-term health.
Learn MoreCombining advanced genomics with population-level insight to enable earlier detection, targeted prevention, and truly personalized care.
Offering targeted, cost-effective panel tests alongside state-of-the-art whole-exome or whole-genome sequencing to enable early identification of:
Hereditary cancer risks
Clinically actionable genetic conditions
Reproductive carrier status
Pharmacogenomic profiles
Polygenic risk scores for common diseases
Virotek brings precision medicine into everyday healthcare. We combine advanced technology, clinically validated results, and a focus on accessibility to empower both patients and healthcare providers.
Comprehensive Testing – From targeted cancer panels to whole-genome sequencing, our portfolio covers a wide range of clinical needs.
Actionable Results – Clear reports aligned with ACMG and CPIC guidelines, helping clinicians make confident decisions.
Secure and Accredited – CLIA-certified, CAP-accredited testing with HIPAA-aligned data handling.
Complete Oncology Continuum – A full suite of genomic solutions supporting every stage of the patient journey, from risk assessment to early detection to tumor profiling and precision-guided therapy selection.
Scalable & Integrated – Genetic testing solutions that grow with your practice, seamlessly connecting with EMRs, LIMS, and clinical support tools.
Virotek empowers physicians, clinics, fertility centers, and laboratories with advanced genomic testing and clear, guideline-driven reporting. We make precision medicine practical, accessible, and actionable in everyday care.
Comprehensive Testing – A broad genomic portfolio spanning targeted panels to whole-genome sequencing, supporting diverse clinical applications across the care continuum.
Clinically Actionable Reports – Guideline-driven interpretations that are designed to support confident decision-making.
Seamless Clinical Integration – Streamlined ordering and reporting system with EMR/LIMS integration and secure clinician portals.
Leading clinics and health systems rely on our genetic testing expertise.
Virotek's Heredi-Tek panel has transformed our hereditary cancer screening program. The results are comprehensive, actionable, and delivered with exceptional clinical interpretation that helps us provide better patient care.
The PRS-TEK polygenic risk scores have been invaluable for our preventive medicine practice. Our patients now have personalized risk assessments that guide targeted interventions and lifestyle modifications with remarkable precision.
Working with Virotek's genetic counseling team has enhanced our ability to interpret complex results and communicate effectively with patients. Their expertise in ACMG guidelines ensures we provide the highest standard of care.
The Exo-Tek whole exome analysis helped us identify a rare genetic condition in a patient with an unclear diagnosis. The comprehensive reporting and pharmacogenomic insights were instrumental in developing a personalized treatment plan.
Virotek's pharmacogenomic testing has revolutionized our approach to medication selection. We can now optimize drug therapies based on individual genetic profiles, reducing adverse reactions and improving patient outcomes significantly.
The integration with our EMR system is seamless, and the turnaround times are exceptional. Virotek consistently delivers high-quality genetic testing results that our fertility clinic relies on for comprehensive patient care.
As a primary care physician, I appreciate how Virotek's genetic testing helps me identify at-risk patients early. The clear clinical recommendations and genetic counselor support make it easy to implement preventive strategies.
Virotek's Geno-Tek whole genome sequencing provides unparalleled depth of analysis for our precision medicine program. The comprehensive insights help us tailor treatments and prevention strategies with exceptional precision.
Common questions about genetic testing and our laboratory services.
Genetic testing can be valuable for many individuals, including:
Those with a personal or family history suggestive of inherited conditions
Individuals starting new medications or with a history of adverse drug responses
Anyone looking to take a more proactive, preventive approach to their health
Proactive screening is particularly recommended for adults over 50, where genetic insights can help guide early detection and personalized care strategies.
We accept saliva samples and blood samples (EDTA tubes). Our collection kits include detailed instructions and prepaid shipping.
Sample quality is validated upon receipt to ensure optimal testing results.
We maintain the highest standards of data security and privacy protection, in accordance with HIPAA and applicable state privacy laws. Genetic information is also protected under the federal Genetic Information Nondiscrimination Act (GINA) for health insurance and employment.
All genetic information is de-identified, securely stored, and accessible only to authorized healthcare providers and patients through secure portals.
Most genetic tests are completed within 10-14 business days from sample receipt. Urgent cases can be expedited.
Yes, we have certified genetic counselors available to support both healthcare providers and patients.
We offer genetic counseling to ensure optimal clinical decision-making and patient understanding.
Results are delivered through secure portals with comprehensive clinical reports following ACMG guidelines.
Each report includes variant classification, clinical significance, and actionable recommendations with literature references for evidence-based decision making.
A PRS combines many common genetic variants to estimate relative risk for complex diseases.
It’s not diagnostic and should be used with clinical factors (age, sex, labs, lifestyle, family history). PRS performance can vary by ancestry.
Single gene variant looks for rare, high-impact variants (e.g., BRCA1/2) that can greatly increase risk. PRS aggregates many small-effect variants to provide a risk estimate.
It’s possible to have negative single gene testing yet a high PRS, or vice versa; they answer different questions and can be complementary.
PGx identifies genetic differences affecting drug metabolism or response (e.g., clopidogrel, SSRIs, opioids).
Results are stable for life and can help your clinician choose or dose medications more safely and effectively.
Keep your PGx report accessible and share it with your care team.
Often, yes. We provide targeted familial testing for at-risk relatives and can help coordinate cascade testing with appropriate counseling.
Science evolves. New evidence can reclassify variants or refine PRS and clinical guidance. For WGS and many panels, we offer periodic reanalysis or clinician-initiated re-review.
Tests are ordered by a licensed physician so they are used and interpreted in the appropriate clinical context.
Coverage depends on the patient's insurance plan. Confirm eligibility directly with the insurance provider.